LIPOCINE INC. Professional Fees
LIPOCINE INC. (LPCN) reported Professional Fees of $43.22 thousand for the 21-month period ending 2013-06-30, per its 10-Q filed 2013-07-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProfessionalFees · last filed 2013-07-09
- LIPOCINE INC. professional fees for the quarter ending 2013-06-30 was $2.39K, a 89.85% decline year-over-year.
- LIPOCINE INC. professional fees for the quarter ending 2013-03-31 was $2.30K, a 90.23% decline year-over-year.
- LIPOCINE INC. professional fees for the quarter ending 2012-12-31 was $4.90K, a 78.96% increase year-over-year.
- LIPOCINE INC. professional fees for the quarter ending 2012-09-30 was $5.20K.
- LIPOCINE INC. professional fees for fiscal 2012 was $35.79K, a 1207.23% increase from fiscal 2011.
- LIPOCINE INC. professional fees for fiscal 2011 was $2.74K.
| Period end | Professional Fees 3 month | Professional Fees 3 month as first filed | Professional Fees 6 month | Professional Fees 9 month | Professional Fees 12 month | Professional Fees 15 month | Professional Fees 18 month | Professional Fees 21 month |
|---|---|---|---|---|---|---|---|---|
| 2013-06-30 | $2.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-09 | $4.69K 10-Q · filed 2013-07-09 | $9.59K derived: sum of 3 quarters · filed 2013-07-09 | $14.79K derived: sum of 4 quarters · filed 2013-07-09 | $43.22K 10-Q · filed 2013-07-09 | |||
| 2013-03-31 | $2.30K 10-Q · filed 2013-07-09 | $2.39K 10-Q · filed 2013-04-24 | $7.20K derived: sum of 2 quarters · filed 2013-07-09 | $12.40K derived: sum of 3 quarters · filed 2013-07-09 | $35.94K derived: sum of 4 quarters · filed 2013-07-09 | $40.92K 10-Q · filed 2013-04-24 | ||
| 2012-12-31 | $4.90K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $10.10K derived: sum of 2 quarters · filed 2013-02-26 | $33.64K derived: sum of 3 quarters · filed 2013-02-26 | $35.79K 10-K · filed 2013-02-26 | $38.53K 10-K · filed 2013-02-26 | |||
| 2012-09-30 | $5.20K 10-Q · filed 2012-10-26 | $28.74K derived: sum of 2 quarters · filed 2012-10-26 | $30.89K 10-Q · filed 2012-10-26 | $33.63K 10-Q · filed 2012-10-26 | ||||
| 2012-06-30 | $23.54K 10-Q · filed 2012-07-18 | $25.69K 10-Q · filed 2013-07-09 | $28.43K 10-Q · filed 2012-07-18 | $49.81K derived: sum of 4 quarters · filed 2013-07-09 | ||||
| 2012-03-31 | $23.54K 10-Q · filed 2013-07-09 | $2.15K 10-Q · filed 2012-05-14 | $4.89K 10-Q · filed 2012-05-14 | $26.28K derived: sum of 3 quarters · filed 2013-07-09 | ||||
| 2011-12-31 | $2.74K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $2.74K derived: sum of 2 quarters · filed 2013-02-26 | $2.74K 10-K · filed 2013-02-26 | |||||
| 2011-09-30 | $0.00 10-Q · filed 2012-10-26 | $0.00 10-Q · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |